This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Large-scale mapping of the MCH network in ALS mice reveals the vulnerability of dopaminergic and GABAergic neurons in zona incerta.
Acta neuropathologica communications · 2026
Protocol for autofluorescence removal in microglia by photobleaching in free-floating immunofluorescent staining of mouse brain tissue.
STAR protocols · 2025 · senior author
Interventionally targeting somatic CAG expansions can be a rapid disease-modifying therapeutic avenue: Preclinical evidence.
bioRxiv : the preprint server for biology · 2025
Latest funding
- $952,426
Determining the mechanism underlying selective neuronal vulnerability in ALS
CIHR · 2021 · Nominated PI
- $500,000
Canada Reseach Chair - Tier 2
CIHR · 2021 · Nominated PI
- $259,000
Control of gene expression during neuronal development
NSERC · 2018 · Principal investigator
14 publications.
Large-scale mapping of the MCH network in ALS mice reveals the vulnerability of dopaminergic and GABAergic neurons in zona incerta.
Scekic-Zahirovic J, Antonucci S, Wiesner D, Ebner C, El Hajj H, Aousji O, Halablab K, Fan Y, Zelaya A, Yartas G, Baskar K, Çakmak EA, Bayer D, Sung HK, Dupuis L, Park J, Roselli F
Protocol for autofluorescence removal in microglia by photobleaching in free-floating immunofluorescent staining of mouse brain tissue.
Metri MN, You J, Park J
Interventionally targeting somatic CAG expansions can be a rapid disease-modifying therapeutic avenue: Preclinical evidence.
Gall-Duncan T, Ko SY, Quick IK, Khan M, Feng K, Kelley CP, Coleman A, Touze A, Tang S, Mehkary M, Yokoi K, Herrington CR, You J, Lambie SC, Prasolava TK, Panigrahi GB, Park J, Nakatani K, Byrne LM, Wang P, Schneekloth JS, Nakamori M, Frankland PW, Wang ET, Pearson CE
Knockout of Dectin-1 does not modify disease onset or progression in a MATR3 S85C knock-in mouse model of ALS.
You J, Maksimovic K, Metri MN, Schoeppe A, Chen K, Lee J, Santos JR, Youssef MMM, Salter MW, Park J
MATR3's Role beyond the Nuclear Matrix: From Gene Regulation to Its Implications in Amyotrophic Lateral Sclerosis and Other Diseases.
Santos JR, Park J
MATR3 pathogenic variants differentially impair its cryptic splicing repression function.
Khan M, Chen XXL, Dias M, Santos JR, Kour S, You J, van Bruggen R, Youssef MMM, Wan YW, Liu Z, Rosenfeld JA, Tan Q, Pandey UB, Yalamanchili HK, Park J
Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential.
You J, Youssef MMM, Santos JR, Lee J, Park J
LONRF2 is a gatekeeper against protein aggregation in aging neurons.
Youssef MMM, Park J
Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.
Maksimovic K, Youssef M, You J, Sung HK, Park J
Selective Loss of MATR3 in Spinal Interneurons, Upper Motor Neurons and Hippocampal CA1 Neurons in a MATR3 S85C Knock-In Mouse Model of Amyotrophic Lateral Sclerosis.
You J, Maksimovic K, Lee J, Khan M, Masuda R, Park J
Determining the mechanism underlying selective neuronal vulnerability in ALS
Principal investigators: Park, Jeehye
Keywords: Amyotrophic Lateral Sclerosis; Matr3; Molecular Biology; Molecular Mechanism; Motor Neuron Degeneration; Mouse Models; Purkinje Cell Degeneration; Rna Splicing; Selective Neuronal Vulnerability; Single Nucleus Rna Sequencing
Canada Reseach Chair - Tier 2
Principal investigators: Park, Jeehye
Keywords: Crc
Control of gene expression during neuronal development
Principal investigators: Park, Jeehye
Control of gene expression during neuronal development
Principal investigators: Park, Jeehye
CRC Tier 2
Principal investigators: Park, Jeehye
Keywords: Crc
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.